FTC Sues Transgender Health Group Over Minor Care Claims
FTC and four states sue WPATH for allegedly misleading claims about care for transgender minors.
Why it matters: This lawsuit challenges regulatory boundaries on healthcare communications and could reshape legal standards for transgender medical care involving minors.
- FTC and Alaska, Iowa, Nebraska, and Texas sued WPATH on June 17, 2026, alleging deceptive claims about gender-affirming care for minors.
- The lawsuit seeks to stop WPATH from making further false claims and to impose financial penalties.
- WPATH’s Standards of Care, guiding transgender healthcare since 1979, were last updated in 2022.
- In May 2026, a federal judge granted WPATH a preliminary injunction suspending the FTC’s investigation.
On June 17, 2026, the Federal Trade Commission (FTC), joined by Alaska, Iowa, Nebraska, and Texas, filed suit against the World Professional Association for Transgender Health (WPATH), alleging that WPATH made unsubstantiated and misleading statements concerning the safety and efficacy of gender-affirming treatments for minors. The complaint claims WPATH failed to adequately disclose potential risks and harms, raising concerns about deceptive marketing practices.
According to the FTC’s official case documents, the agency seeks injunctive relief to prevent future violations and financial penalties related to these alleged misrepresentations. Precise penalty figures have not been disclosed publicly.
WPATH, established in 1979, is a prominent international organization that develops clinical guidelines on transgender health. Its most recent publication, the eighth edition of the Standards of Care (SOC 8), issued in 2022, is widely referenced by medical professionals. The SOC 8 outlines recommended practices for gender-affirming care across age groups, including minors.
In response to the FTC investigation, WPATH filed a lawsuit in February 2026 challenging the commission’s authority and alleging constitutional violations. On May 7, 2026, U.S. District Judge James Boasberg granted a preliminary injunction halting the FTC’s inquiry pending further proceedings.
FTC Chairman Andrew Ferguson stated, "Parents have a right to make informed decisions about their children’s health. The FTC will not allow deceptive claims that put children at risk." WPATH countered that the investigation is a "government campaign to harass and intimidate medical providers," affirming its commitment to evidence-based care.
This case occurs amid increasing regulatory and legal scrutiny over transgender healthcare for minors. Its resolution may define limits on regulatory authority regarding healthcare communications and shape compliance obligations for medical organizations providing gender-affirming care.
By the numbers:
- June 17, 2026 — Date FTC and four states filed lawsuit against WPATH
- 2022 — Year WPATH published its eighth edition of the Standards of Care
- May 7, 2026 — Date federal judge granted preliminary injunction pausing FTC investigation
Yes, but: While the FTC alleges deceptive practices, WPATH argues the investigation infringes on constitutional and medical standards, highlighting complex legal and ethical disputes.
What's next: Ongoing court proceedings will determine the scope of regulatory oversight and may set precedents for future healthcare-related communications and enforcement.